|  | 
	
	| (2Z)-2-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-7,8-dimethyl[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one |  | Pseudomonas Yersinia
 | TTSS (Type III secretion system) TTSS (Type III secretion system)
 | Preclinical (in vitro) Preclinical (in vitro)
 | Harmon DE, et al. 2010. Antimicrob Agents Chemother 
 | 
	|  | 
	
	| (5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine | Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
H
N
H
2
N | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| 5beta,6alpha-Bis(4-cyclohexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
N
H
NH
2 | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| 5beta,6alpha-Bis(4-cyclopropyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
H
2
N
N
H
N
N
N
N
H
H
N
N
N | Pseudomonas | Biofilm | Preclinical (in vitro) | Huigens RW 3rd, et al. 2009. Org Biomol Chem | 
	|  | 
	
	| 5beta,6alpha-Bis(4-heptyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
H
3
C
N
N
N
HN
H
2
N
N
N
N
N
H
3
C
H
H | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| 5beta,6alpha-Bis(4-hexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
H
3
C
N
N
N
N
H
H
2
N
N
N
N
N
H
3
C
H
H | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| 5beta,6alpha-Bis(4-pentyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
N
N
H
3
C
N
HN
H
2
N
N
N
N
N
H
3
C
H
H | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| 5beta,6alpha-Bis(4-phenyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine | Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
N
H
NH
2 | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
	|  | 
	
	| (5R,6R)-5,6-bis[[4-(2-phenylethyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine | Depiction based on curated SMILES
N
H
N
N
N
N
NH
N
H
N
NH
2 | Acinetobacter Pseudomonas
 Staphylococcus
 | Biofilm Biofilm
 Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 
 | 
	|  | 
	
	| (5R,6R)-5,6-bis[[4-(3-methylbutyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine | Depiction based on curated SMILES
N
N
H
3
C
CH
3
N
N
H
H
2
N
N
N
N
CH
3
N
H
3
C
H
H | Acinetobacter Pseudomonas
 | Biofilm Biofilm
 | Preclinical (in vitro) Preclinical (in vitro)
 | Huigens RW 3rd, et al. 2009. Org Biomol Chem 
 | 
|  | 
	|  |  |  |